NCT00727467

Brief Summary

The primary aim of the study is to evaluate the effect of an IACD i.e. Apple iPod-shuffle, on freezing and gait speed in people with a diagnosis of PD through the implementation of a randomised controlled trial. A secondary aim of the study is to evaluate the impact of such a device on the quality of life of people with stroke through the administration of a self-report questionnaire. The IACD will be pre-loaded with an individualised auditory cueing frequency (metronome sound) matched to the walking speed of the individual with PD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
47

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Sep 2008

Shorter than P25 for phase_1

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2008

Completed
28 days until next milestone

Study Start

First participant enrolled

September 1, 2008

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
Last Updated

December 31, 2008

Status Verified

August 1, 2008

Enrollment Period

3 months

First QC Date

July 31, 2008

Last Update Submit

December 30, 2008

Conditions

Keywords

auditory cueing deviceParkinson's diseasefreezinggaitmobility

Outcome Measures

Primary Outcomes (1)

  • Freezing of Gait Questionnaire

    Day 8, Day 15, Day 23 and 3 month follow up

Secondary Outcomes (3)

  • Timed Up and Go Test

    Day 8, Day 15, Day 23 and three month follow-up

  • Modified Falls Efficacy Scale

    Day 8, Day 15, Day 23 and three month follow-up

  • 10 Metre Walk Test

    Day 8, Day 15, Day 23 and three month follow-up

Study Arms (2)

A

EXPERIMENTAL

On Days 1-8 of the trial, participants in Group A will be given the iPod with some music on the device to allow all participants to become familiar with the device i.e. turning device on and off, increasing and decreasing the volume. They will be instructed to use the device only when sitting at home, and that the device should not be turned on when walking or performing any mobility related or daily tasks. On Days 8-15, participants in Group A will be allocated to the 'intervention' phase. Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks. On Days 15-23, participants in Group A will be allocated to the 'control' phase. During this time period, participants will be provided with the iPod shuffle containing no music or metronome beat.

Device: Auditory Cueing Device

B

ACTIVE COMPARATOR

On Days 1-8 of the trial, participants in Group B will be given the iPod with some music on the device to allow all participants to become familiar with the device. They will be instructed to use the device only when sitting at home, and that the device should not be turned on when walking or performing any mobility related or daily tasks. On Days 8-15, participants in Group B will be allocated to the 'control' phase. During this time period, participants will be provided with the iPod shuffle containing no music or metronome beat. On Days 15-23, participants in Group B will be allocated to the 'intervention phase'. Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks.

Device: Auditory Cueing Device

Interventions

Each participant will be given an iPod containing an auditory cue in the form of a continuous metronome beat, individualised to the patient's walking frequency (less 10%).Participants will be instructed to listen to the cueing when they are performing any mobility related tasks.

Also known as: iPod shuffle
AB

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • medically stable
  • willing to give informed consent
  • freeze at least once per week (minimum score of 2 on item 3 of the FOGQ) for at least 2 seconds(minimum score of 1 on item 4 of FOGQ)
  • MMSE Score greater than 24

You may not qualify if:

  • attending physiotherapy at time of recruitment
  • unwilling to give informed consent
  • not medically stable
  • cognitive impairment (MMSE score less than 24)
  • acure co-morbidity that prevents mobility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cork University Hospital

Cork, Ireland

Location

Royal Hospital Donnybrook

Dublin, Ireland

Location

Saint James's Hospital

Dublin, Ireland

Location

Related Publications (1)

  • Ledger S, Galvin R, Lynch D, Stokes EK. A randomised controlled trial evaluating the effect of an individual auditory cueing device on freezing and gait speed in people with Parkinson's disease. BMC Neurol. 2008 Dec 11;8:46. doi: 10.1186/1471-2377-8-46.

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Emma K Stokes, PhD

    University of Dublin, Trinity College

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Emma K Stokes, PhD

CONTACT

Rose Galvin, BSc

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 31, 2008

First Posted

August 4, 2008

Study Start

September 1, 2008

Primary Completion

December 1, 2008

Study Completion

March 1, 2009

Last Updated

December 31, 2008

Record last verified: 2008-08

Locations